mhurhangee/ep-ind-claims huggingface dataset:
A method for a base station to configure a bearer for transport of user data in a user plane based cellular Internet of Things, CIoT, in a wireless communication system, the method comprising: receiving an RRC Connection Resume Request message including a tracking area update, TAU, request message from a user equipment, UE, transmitting an initial UE message comprising the TAU request message to a mobility management entity, MME, receiving a downlink NAS transport message comprising a Resume Indication from the MME, and transmitting a UE Context Resume Request message to the MME based on the Resume Indication, wherein the RRC Connection Resume Request message does not include a bearer indication, and wherein a suspension of an RRC connection is prohibited and a transmission of the UE Context Resume Request message is triggered by the Resume Indication. receiving an RRC Connection Resume Request message including a tracking area update, TAU, request message from a user equipment, UE, transmitting an initial UE message comprising the TAU request message to a mobility management entity, MME, receiving a downlink NAS transport message comprising a Resume Indication from the MME, and transmitting a UE Context Resume Request message to the MME based on the Resume Indication, wherein the RRC Connection Resume Request message does not include a bearer indication, and wherein a suspension of an RRC connection is prohibited and a transmission of the UE Context Resume Request message is triggered by the Resume Indication.
A flexible closing dressing bolster for use with a system for treating a linear wound on a patient's joint, the flexible closing dressing bolster comprising: a bolster body having a first side, the first side comprising apertures for receiving reduced pressure, a second, inward-facing side, wherein the bolster body is formed with a plurality of flexion joints, which are formed with sl ots that extend from the first side into the bolster body, and a central compartment having the slots but is seal ed by a drape, and wherein the flexible closing bolster is arranged such that as reduced pressure enters the apertures, a central compartment is evacuated and collapses such that a lower portion of a central trough contacts a shelf portion, and wherei n reduced pressure enters into a treatment trough through apertures in the shelf portion, and the treatment trough includes oblique walls, wherein the reduced pressure i n the treatment trough acts on the obl i que walls and pulls them towards each other and wherei n these acti ons cause the bolster body to bend about the central trough and causes a first closing member formed on a first longitudinal side of a centre wound area of the flexible closing dressing bolster body and a second closing member formed on a second longitudinal side of a centre wound area of the flexible closing dressing bolster body to be urged towards each other. a bolster body having a first side, the first side comprising apertures for receiving reduced pressure, a second, inward-facing side, wherein the bolster body is formed with a plurality of flexion joints, which are formed with sl ots that extend from the first side into the bolster body, and a central compartment having the slots but is seal ed by a drape, and wherein the flexible closing bolster is arranged such that as reduced pressure enters the apertures, a central compartment is evacuated and collapses such that a lower portion of a central trough contacts a shelf portion, and wherei n reduced pressure enters into a treatment trough through apertures in the shelf portion, and the treatment trough includes oblique walls, wherein the reduced pressure i n the treatment trough acts on the obl i que walls and pulls them towards each other and wherei n these acti ons cause the bolster body to bend about the central trough and causes a first closing member formed on a first longitudinal side of a centre wound area of the flexible closing dressing bolster body and a second closing member formed on a second longitudinal side of a centre wound area of the flexible closing dressing bolster body to be urged towards each other.
Method for operating, in hot stand-by mode, a fuel cell (SOFC) or a high temperature co-electrolysis or electrolysis reactor having a stack of elementary electrochemical cells of the solid oxide type (SOEC), the method comprising, for a given period of time in which there is no electrical current exiting and/or applied to the stack, or when the temperature of the cell or the reactor is to be raised or lowered, a step of supplying pulses of a safety gas to the compartments on the side of the hydrogen/water (H 2 /H 2 O) electrodes, at regular intervals for the given period of time, or when the cell voltage drops below a threshold value, so as to renew the gas(es) present in said compartments.
Phase modulator for a light flow comprising an entry guide and at least one multimode modulation guide having an entry optically coupled to an exit of the entry guide, an exit and a principal propagation axis (y) along which a light flow is intended to pass through the modulation guide, the modulation guide further comprising: - at least one p-doped region and a n-doped region so as to define a p-n junction generating a space charge region, - a device configured to vary a voltage V applied between the n- and p-doped regions (5, 4) so as to vary the phase of the light flow intended to propagate in the modulation guide, characterised in that the entry guide is configured to excite various propagation modes in the modulation guide and in that the p-n junction mainly extends along the principal propagation axis (y) and following an oscillating continuous function forming oscillations each defining a peak and wherein the peaks of two successive oscillations are separated by a distance P jPN. - at least one p-doped region and a n-doped region so as to define a p-n junction generating a space charge region, - a device configured to vary a voltage V applied between the n- and p-doped regions (5, 4) so as to vary the phase of the light flow intended to propagate in the modulation guide,
Hydraulic master brake cylinder for a vehicle brake system, having a brake force booster and having a thrust rod piston which can be displaced in the master brake cylinder, for actuating the vehicle brake system, by muscle force and/or by the brake force booster, wherein the master brake cylinder has two thrust rod pistons (2, 3) which are displaceable relative to one another, and one thrust rod piston of which can be displaced in the master brake cylinder by muscle force and the other thrust rod piston of which can be displaced in the master brake cylinder by the brake force booster, wherein one of the two thrust rod pistons is a tubular hollow piston, wherein the two thrust rod pistons (2, 3) are situated one inside the other, wherein the outer tubular thrust rod piston closes off a breather bore via which a brake fluid reservoir communicates with a pressure chamber of the master brake cylinder, characterized in that the inner thrust rod piston is actuated by the brake force booster and the outer tubular thrust rod piston is actuated by muscle force.
Method for using a device for emptying a container bag or an emptied tubular container bag from a device for filling bulk material, comprising the following features: a) the device has a housing for receiving pourable material, which can be transferred into the container bag and disposed of after use or emptying of the pourable material via an outlet opening or an outlet nozzle having an outlet opening; b) the outlet nozzle is connected to the housing; c) an opening is provided between the outlet nozzle and the housing; characterised by the following features: d) a film tube is placed on the outer circumference of the housing wall of a nozzle closure, the end of which is guided around the housing wall and placed against an inner wall of the housing wall and sealed with the aid of a closure; e) the nozzle closure is inserted into the inlet nozzle and is used to additionally seal the film tube and the inlet nozzle; f) the nozzle closure is adapted with its outer circumference to the inner circumference of the outlet nozzle and has openings at its two ends which can be closed with the aid of a respective cover (25, 25'). a) the device has a housing for receiving pourable material, which can be transferred into the container bag and disposed of after use or emptying of the pourable material via an outlet opening or an outlet nozzle having an outlet opening; b) the outlet nozzle is connected to the housing; c) an opening is provided between the outlet nozzle and the housing; characterised by the following features: d) a film tube is placed on the outer circumference of the housing wall of a nozzle closure, the end of which is guided around the housing wall and placed against an inner wall of the housing wall and sealed with the aid of a closure; e) the nozzle closure is inserted into the inlet nozzle and is used to additionally seal the film tube and the inlet nozzle; f) the nozzle closure is adapted with its outer circumference to the inner circumference of the outlet nozzle and has openings at its two ends which can be closed with the aid of a respective cover (25, 25').
Drafting device for use in spinning machinery and for drafting discontinuous fibers, such as cotton, linen, wool, jute, ramie, hemp or man-made fibers, with a pair of feed rollers, a pair of draft rollers, a pair of control rollers and a pair of delivery rollers, being arranged in this order in a rove feed direction defining a drafting zone composed of three sub-drafting zones (A, B, C), whereby the rollers (2, 3, 4) are driven at a respective predetermined speed in such a manner that a drafting action is exerted on the rove, characterized in that said control rollers are both provided with an active drive mechanism, that said control rollers are mounted in a fixed but contact-free manner with a defined control gap between them of a predetermined dimension, that said control gap between the control rollers is set in the range of 0.1 mm to 1 mm, preferably 0.1 mm to 0.3 mm, and that said control rollers have a hard control outer surface made of a metal or a metal alloy material, preferably chrome.
A copper complex of formula A where X = Cl, Br, I, CN, SCN, alkinyl, and/or N 3 (independently of each other); N*∩E = a bidentate ligand wherein E = phosphinyl/arsenyl group of the R 2 E form (wherein R = alkyl, aryl, alkoxy, phenoxy or amide); N* = imine function which is part of an N-heteroaromatic 5-membered ring that is selected from the group consisting of pyrazole, isoxazole, isothiazole, triazole, oxadiazole, thiadiazole, tetrazole, oxatriazole and thiatriazole; "∩" = at least one carbon atom which is likewise part of the aromatic group, wherein the carbon atom is directly adjacent both to the imine nitrogen atom and to the phosphorus or arsenic atom, wherein N*∩E optionally comprises at least one substituent for increasing the solubility of the copper complex in an organic solvent. X = Cl, Br, I, CN, SCN, alkinyl, and/or N 3 (independently of each other); N*∩E = a bidentate ligand wherein E = phosphinyl/arsenyl group of the R 2 E form (wherein R = alkyl, aryl, alkoxy, phenoxy or amide); N* = imine function which is part of an N-heteroaromatic 5-membered ring that is selected from the group consisting of pyrazole, isoxazole, isothiazole, triazole, oxadiazole, thiadiazole, tetrazole, oxatriazole and thiatriazole; "∩" = at least one carbon atom which is likewise part of the aromatic group, wherein the carbon atom is directly adjacent both to the imine nitrogen atom and to the phosphorus or arsenic atom, wherein N*∩E optionally comprises at least one substituent for increasing the solubility of the copper complex in an organic solvent. E = phosphinyl/arsenyl group of the R 2 E form (wherein R = alkyl, aryl, alkoxy, phenoxy or amide); N* = imine function which is part of an N-heteroaromatic 5-membered ring that is selected from the group consisting of pyrazole, isoxazole, isothiazole, triazole, oxadiazole, thiadiazole, tetrazole, oxatriazole and thiatriazole; "∩" = at least one carbon atom which is likewise part of the aromatic group, wherein the carbon atom is directly adjacent both to the imine nitrogen atom and to the phosphorus or arsenic atom, wherein N*∩E optionally comprises at least one substituent for increasing the solubility of the copper complex in an organic solvent.
Pharmaceutical composition comprising or consisting of a) isolated whole blood cells and / or Peripheral Blood Mononuclear Cells (PBMCs) treated with a therapeutically effective amount of an active substance, and b) optionally a pharmaceutically acceptable carrier, for use in the prevention and / or treatment of organ or cell graft rejection in a human graft recipient, wherein the isolated whole blood cells or PBMCs are obtained or derived from the graft donor, wherein the prevention and / or treatment of organ or cell graft rejection comprises administering the pharmaceutical composition to the recipient, wherein the amount of the pharmaceutical composition is selected such that at least 1.5 × 10 6 cells of the treated whole blood cells or the treated PBMCs per kg body weight of the recipient are administered, preferably in one administration step, wherein the prevention and / or treatment of organ or cell graft rejection comprises administering to the recipient at least 1 × 10 8 cells of the treated whole blood cells or the treated PBMCs per kg body weight of the recipient, wherein the administration is performed at least 5 days before the transplantation, wherein the active substance comprises or consists of one or more substances selected from the group consisting of chemotherapeutics, proteasome inhibitors, immunosuppressive agents, anti-proliferative substances and combinations thereof. a) isolated whole blood cells and / or Peripheral Blood Mononuclear Cells (PBMCs) treated with a therapeutically effective amount of an active substance, and b) optionally a pharmaceutically acceptable carrier, for use in the prevention and / or treatment of organ or cell graft rejection in a human graft recipient, wherein the isolated whole blood cells or PBMCs are obtained or derived from the graft donor, wherein the prevention and / or treatment of organ or cell graft rejection comprises administering the pharmaceutical composition to the recipient, wherein the amount of the pharmaceutical composition is selected such that at least 1.5 × 10 6 cells of the treated whole blood cells or the treated PBMCs per kg body weight of the recipient are administered, preferably in one administration step, wherein the prevention and / or treatment of organ or cell graft rejection comprises administering to the recipient at least 1 × 10 8 cells of the treated whole blood cells or the treated PBMCs per kg body weight of the recipient, wherein the administration is performed at least 5 days before the transplantation, wherein the active substance comprises or consists of one or more substances selected from the group consisting of chemotherapeutics, proteasome inhibitors, immunosuppressive agents, anti-proliferative substances and combinations thereof.
An artificial airway including an airway tube having proximal and distal ends and a mask mounted at the distal end of the airway tube, wherein the airway tube includes a curved portion adjacent to its distal end and a straight portion extending from the curved portion to the proximal end of the airway tube wherein the curved portion is more rigid than the straight portion, characterised in that the curved portion is moulded from a first material which is less flexible than a second material from which the straight portion is moulded.
A node comprising: a receiver adapted to receive pilot data from a base station that is transmitted from multiple antennas; logic circuitry adapted to determine null subspace information and channel subspace information based on the received pilot data, wherein the null subspace information, when used by the base station to compute transmit antenna weights, results in minimal received power at the node, and wherein the channel subspace information, when used by the base station to compute transmit antenna weights, results in maximal received power at the node; and transmitting circuitry adapted to transmit the null subspace information and the channel subspace information for use by the base station in determining antenna weights. a receiver adapted to receive pilot data from a base station that is transmitted from multiple antennas; logic circuitry adapted to determine null subspace information and channel subspace information based on the received pilot data, wherein the null subspace information, when used by the base station to compute transmit antenna weights, results in minimal received power at the node, and wherein the channel subspace information, when used by the base station to compute transmit antenna weights, results in maximal received power at the node; and transmitting circuitry adapted to transmit the null subspace information and the channel subspace information for use by the base station in determining antenna weights.
Non-invasive device for determining the fertility and/or sex of an egg, characterised in that it comprises means (200; 400) for obtaining a spectral response, specific to the shell, to an incident light signal, comprising focusing means (110, 104; 410, 404) configured to focus said incident light signal on a surface portion and/or an internal portion of at least one layer of the shell, and means (300; 500) for determining the fertility and/or sex of the egg as a function of said spectral response specific to the shell.
Massage device suitable for massage of the Achilles tendon (tendo Achillis) with the leg extended, the massage device having: - a housing having a housing base (103") for placement on a flat surface; - two massage means (3, 3") projecting at least partially from the housing, which are drivable about a rotational axis in each case by a motor, wherein the rotational axes are aligned perpendicular with respect to the longitudinal direction of the leg, wherein the massage means (3, 3') are arranged on the housing and with respect to each other in such a way, that they at least partially place the Achilles tendon between them, - a rest device arranged above the housing suited for resting the leg during the massage, wherein at least one of the massage means (3, 3') has a plurality of massage heads, preferably in each case three massage heads, wherein one of the massage heads, preferably all massage heads, is freely rotatable about a rotational axis in each case. - a housing having a housing base (103") for placement on a flat surface; - two massage means (3, 3") projecting at least partially from the housing, which are drivable about a rotational axis in each case by a motor, wherein the rotational axes are aligned perpendicular with respect to the longitudinal direction of the leg, wherein the massage means (3, 3') are arranged on the housing and with respect to each other in such a way, that they at least partially place the Achilles tendon between them, - a rest device arranged above the housing suited for resting the leg during the massage, wherein at least one of the massage means (3, 3') has a plurality of massage heads, preferably in each case three massage heads, wherein one of the massage heads, preferably all massage heads, is freely rotatable about a rotational axis in each case.
A motorcycle pneumatic tire comprising: a tread portion comprising a crown region (Cr), a pair of middle regions (Mr) and a pair of shoulder regions (Sr) upon a tread development width of the tread portion being divided equally into said five regions; the tread portion being provided with at least a pair of circumferentially and continuously extending crown main grooves within the crown region (Cr) to include a tire equator therebetween and a plurality of inclined grooves each extending from the crown region (Cr) to the shoulder region (Sr) in each side of the tire equator without communicating with the crown main grooves; and each of the inclined grooves comprising a straight portion extending straightly in the middle region (Mr) and an arc portion extending in an arc shape in the shoulder region (Sr) while increasing an angle (θ2) with respect to a circumferential direction of the tire axially outwardly, wherein a middle land portion is defined between straight portions of a pair of circumferentially adjacent inclined grooves in each middle region (Mr), characterized in that a width (Wa) of the middle land portion in a direction perpendicular to the straight portions is in a range of from 115% to 165% of a width of the straight portions. a tread portion comprising a crown region (Cr), a pair of middle regions (Mr) and a pair of shoulder regions (Sr) upon a tread development width of the tread portion being divided equally into said five regions; the tread portion being provided with at least a pair of circumferentially and continuously extending crown main grooves within the crown region (Cr) to include a tire equator therebetween and a plurality of inclined grooves each extending from the crown region (Cr) to the shoulder region (Sr) in each side of the tire equator without communicating with the crown main grooves; and each of the inclined grooves comprising a straight portion extending straightly in the middle region (Mr) and an arc portion extending in an arc shape in the shoulder region (Sr) while increasing an angle (θ2) with respect to a circumferential direction of the tire axially outwardly, wherein a middle land portion is defined between straight portions of a pair of circumferentially adjacent inclined grooves in each middle region (Mr), characterized in that a width (Wa) of the middle land portion in a direction perpendicular to the straight portions is in a range of from 115% to 165% of a width of the straight portions.
High-frequency electro medical device for pain therapy and physiotherapy, emitting waves at two or more possible discrete and pre-established operation frequencies, activate the cell stimulation in muscle and connective tissue, comprising at least one high-frequency generator suited to be connected to a power supply network, at least one hand piece with application head suited to be connected to said generator, said generator, according to the type of treatment to be carried out and to the patient, wherein said generator is configured so that it cannot emit waves at values different from the pre-established operation frequencies of 2 MHz 4 MHz and 8 MHz, selecting one frequency at a time, with adjustable emission power, with an emission cycle having adjustable duration, and the repetition or repetitions of said cycle are programmable, and wherein said electro-medical device comprises: • at least one or two of said hand pieces, each provided with a corresponding, substantially plate-like application head, and wherein said application heads of the two hand pieces come in different sizes, the surface of said plate being subjected to a surface vitrification treatment; • at least one insulated return mat, suited to be electrically connected to said generator in order to close the high-frequency current circuit, and wherein said mat must be placed between the patient and the supporting surface, chair or bed where the patient is positioned; and wherein the maximum power output of the generator is substantially continuous of 100 W rms on a load substantially on 100 Ohm. • at least one or two of said hand pieces, each provided with a corresponding, substantially plate-like application head, and wherein said application heads of the two hand pieces come in different sizes, the surface of said plate being subjected to a surface vitrification treatment; • at least one insulated return mat, suited to be electrically connected to said generator in order to close the high-frequency current circuit, and wherein said mat must be placed between the patient and the supporting surface, chair or bed where the patient is positioned;